Rebeccamycin Analog in Treating Patients With Metastatic or Locally Recurrent Colorectal Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Phase II trial to study the effectiveness of rebeccamycin analog in treating patients who
have metastatic or locally recurrent colorectal cancer. Drugs used in chemotherapy use
different ways to stop tumor cells from dividing so they stop growing or die.